secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2023-09-21T23:59:59+00:00
Accession:  0000947871-23-000948
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health elects Boston Scientific CEO Michael F. Mahoney to board
-------------------------------------------------------------------

- Michael F. Mahoney elected to CVS Health Board, effective November 1, 2023.
- Mahoney has been President and CEO of Boston Scientific (BSX) since 2012.
- Board determined Mahoney independent under NYSE and CVS guidelines.
- Compensation consistent with other non-employee directors, subject to proration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000094787123000948/0000947871-23-000948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000094787123000948/ss2511976_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-23-000948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer